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Abstract
© 2014  Ekaterina  Kuzina  et  al.  We  recently  showed  that  myelin  basic  protein  (MBP)  is
hydrolyzed by 26S proteasome without ubiquitination. The previously suggested concept of
charge-mediated interaction between MBP and the proteasome led us to attempt to compensate
or  mimic  its  positive  charge  to  inhibit  proteasomal  degradation.  We  demonstrated  that
negatively charged actin and calmodulin (CaM), as well  as basic histone H1.3, inhibit  MBP
hydrolysis  by  competing  with  the  proteasome  and  MBP,  respectively,  for  binding  their
counterpart. Interestingly, glatiramer acetate (GA), which is used to treat multiple sclerosis (MS)
and is structurally similar to MBP, inhibits intracellular and in vitro proteasome-mediated MBP
degradation. Therefore, the data reported in this study may be important for myelin biogenesis
in both the normal state and pathophysiological conditions.
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